---
title: Codis vs LGM Pharma
slug_a: codis
slug_b: lgmpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/codis/lgmpharma
generated_by: BioBM Editorial AI
---

# Codis vs LGM Pharma

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Codis (codis) is listed for cdmo. Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.

Services: 8. Modalities: 1. Indications: 0. Locations: 5. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

LGM Pharma (lgmpharma) is listed for cdmo. LGM Pharma offers full-service CDMO support from concept through commercialization, plus API sourcing. It provides analytical method development and stability testing for APIs and drug products, with regulatory strategy support for 505(b)(2) and ANDA filings.

Services: 4. Modalities: 1. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.